Paraneoplastic Syndromes - 51 Studies Found
Active, not recruiting |
: Ephedrine for the Treatment of Congenital Myasthenia : Myasthenic Syndromes, Congenital : 2007-10-07 : Drug: Ephedrine |
Available |
: Treatment Use of 3,4 Diaminopyridine in Congenital Myasthenia and Lambert-Eaton Syndrome :
: 2017-02-21 : Drug: 3,4-Diaminopyridine The investigator will prescribe an initial dose of 3,4 diaminopyridine (DAP) b |
Recruiting |
: Phase 3 Study to Evaluate Efficacy of Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS) : Lambert-Eaton Myasthenic Syndrome : 2016-11-16 :
|
Recruiting |
: Amifampridine Phosphate for the Treatment of Congenital Myasthenic Syndromes : Myasthenic Syndromes, Congenital : 2015-09-24 :
|
Available |
: Expanded Access Study Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS), Congenital Myasthenic Syndrome (CMS), or Downbeat Nystagmus Patients :
: 2013-01-06 :
|
Available |
: Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome :
: 2011-12-24 :
|
Completed |
: Pregnancy Outcomes in Congenital Myasthenie Syndrome : Congenital Myasthenic Syndrome : 2011-11-16 |
No longer available |
: Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) With 3, 4 DAP : Lambert Eaton Myasthenic Syndrome (LEMS) : 2011-06-20 : Drug: 3,4-diaminopyridine Treatment will begin with 5mg three times a day or less. |